Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for alleged mismanagement of accounts receivable and insufficient malpractice liability insurance, impacting investors who acquired securities during the specified class period [7]. Group 1: Allegations - The lawsuit claims that Ardent Health reported inflated accounts receivable and delayed recognizing losses on uncollectable accounts during the class period from July 18, 2024, to November 12, 2025 [7]. - It is alleged that the company did not maintain adequate professional malpractice liability insurance to cover potential claims arising from its operations [7]. Group 2: Financial Impact - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised assessments of accounts receivable collectability, which followed a transition to a new revenue accounting system [7]. - Following this announcement, Ardent Health's stock price dropped by $4.75 per share, nearly 34%, from $14.05 to $9.30 per share on November 13, 2025 [7]. Group 3: Legal Proceedings - Investors who purchased Ardent Health securities during the class period have until March 9, 2026, to apply to be appointed as lead plaintiff in the lawsuit [7]. - The law firm Bragar Eagel & Squire, P.C. is representing the investors and encourages those affected to reach out for more information [4][5].
ARDENT HEALTH FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights